John is a health content expert and wellness researcher with a passion for preventative medicine and holistic lifestyle habits. Known for his ability to make intricate health topics easy to digest, John focuses on providing scientifically grounded insights that help readers take control of their long-term well-being. When he isn't researching the latest in clinical wellness, he is exploring the intersection of technology and human performance.
Explore why the Indian pharmaceutical industry is set for sustained double-digit growth driven by complex generics, PLI schemes, and rising domestic demand.
New Phase II data reveals that adding ligufalimab to azacitidine and venetoclax improves overall survival for AML patients. Learn the latest clinical impact.
Discover how closed-loop DBS is revolutionizing CNS clinical trials. Learn why your protocol needs to adapt to real-time neuro-monitoring and data integration.
Discover how small ClinOps teams effectively manage single-drug, multi-indication trials through strategic planning, advanced technology, and lean models.
A new study reveals a lack of medical research in India's private hospitals, urging a shift toward evidence-based medicine to improve patient outcomes.
A new clinical trial reveals that a common MS drug effectively treats Myasthenia Gravis, offering hope for improved management of this autoimmune disorder.